Stocks in Stealth Mode: Revolution Lighting Technologies (NASDAQ:RVLT), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Ocera Therapeutics (NASDAQ:OCRX)

Diamond Offshore Drilling, Inc. (NYSE:DO) shares fell -1.95% in last trading session and ended the day at $23.62. DO Gross Margin is 47.20% and its has a return on assets of -3.60%. Diamond Offshore Drilling, Inc. (NYSE:DO) quarterly performance is 7.41%.

Diamond Offshore Drilling, Inc. (NYSE:DO) announced that Marc Edwards, President and Chief Executive Officer, presented at the DNB Oil, Offshore & Shipping Conference held in Oslo, Norway, on March 2, 2016.

Emerson Electric Co. (NYSE:EMR) ended the last trading day at $54.64. Company weekly volatility is calculated as 2.61% and price to cash ratio as 11.30. Emerson Electric Co. (NYSE:EMR) showed a weekly performance of 6.59%.

Emerson Network Power, a business of Emerson Electric Co. (NYSE:EMR) and the world’s leading provider of critical infrastructure for information and communications technology systems, introduced more efficient, more flexible, high-capacity models to its Liebert® CW line of chilled water cooling systems for data centers.

On 18 March, Revolution Lighting Technologies, Inc. (NASDAQ:RVLT) shares fell -3.35% and was closed at $6.35. RVLT EPS growth in last 5 year was 47.30%. Revolution Lighting Technologies, Inc. (NASDAQ:RVLT) year to date (YTD) performance is -20.63%.

Revolution Lighting Technologies (NASDAQ:RVLT), announced that GB Energie LED, a minority, woman-owned business committed to sourcing sustainable energy solutions, has installed its LED tube technology for Ideal Academy Public Charter School in Washington D.C. The completion of a “Fund, Furnish and Install” LED lighting retrofit for the charter school included the installation of Revolution Lighting’s T8 SEP LED Tubes and Uni-Fit T5 Ballast Ready LED Tubes, combined with occupancy sensor lighting controls throughout all classroom areas.

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) shares increased 4.43% in last trading session and ended the day at $2.83. EPRS has a return on assets of -59.50%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) quarterly performance is -23.31%.

On 15 March, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) reported Revenue totaled approximately $285,000 for the fourth quarter of 2015, compared to $4,000 for the fourth quarter of 2014. The revenue in 2015 related to collaboration revenue under the Polpharma agreement of $185,000, royalties and milestones under the Sun Pharmaceutical agreement of $44,000, and $56,000 related to development service revenues from the recently acquired Bioceros subsidiary in the Netherlands.

Ocera Therapeutics, Inc. (NASDAQ:OCRX) caters to the Healthcare space. Its weekly performance is -19.61%. On the last day of trading company shares ended up at $2.91.

On 3 March, Ocera Therapeutics, Inc. (NASDAQ:OCRX) reported Net loss for the three and twelve months ended December 31, 2015 was $7.1 million and $26.5 million, respectively. Net loss for the three and twelve months ended December 31, 2014 was $5.5 million and $23.4 million, respectively. Basic and diluted net loss per share for the three and twelve months ended December 31, 2015 was $0.34 and $1.32, respectively. Basic and diluted net loss per share for the three and twelve months ended December 31, 2014 was $0.28 and $1.34, respectively.